ClinicalTrials.govpublic full text
FREEDOM COVID-19 Anticoagulation Strategy
covid-19, sars-cov-2, randomization, hospitalization, pcr or antigen positive test, abnormal laboratory maker, anticoagulation, apixaban, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843369
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.